New 52 Week High Today

Guerbet SA 4G8-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 05/03/24 CEST
37.85quote price arrow up+0.65 (+1.75%)
52 week range
15.76 - 37.85
Loading...
  • Open37.85
  • Day High37.85
  • Day Low37.85
  • Prev Close37.35
  • 52 Week High37.85
  • 52 Week High Date05/03/24
  • 52 Week Low15.76
  • 52 Week Low Date10/05/23

Key Stats

  • Market Cap505.98M
  • Shares Out12.62M
  • 10 Day Average Volume15
  • Dividend0.50
  • Dividend Yield1.32%
  • Beta-
  • YTD % Change96.32

KEY STATS

  • Open37.85
  • Day High37.85
  • Day Low37.85
  • Prev Close37.35
  • 52 Week High37.85
  • 52 Week High Date05/03/24
  • 52 Week Low15.76
  • 52 Week Low Date10/05/23
  • Market Cap505.98M
  • Shares Out12.62M
  • 10 Day Average Volume15
  • Dividend0.50
  • Dividend Yield1.32%
  • Beta-
  • YTD % Change96.32

RATIOS/PROFITABILITY

  • EPS (TTM)1.94
  • P/E (TTM)19.51
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/29/2023
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest On Guerbet SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such...
Didier Izabel
Independent Chairman of the Board
Jerome Estampes
Chief Financial Officer, Senior Vice President - IT and Business Development and Licensing, Member of the Executive Committee
Address
15 rue des Vanesses, Zone Paris Nord II
Villepinte
93420
France